AMGN v. TKTX: Waiting for Round 2

When attorneys for Amgen Inc. and Transkaryotic Therapies Inc. appear in trial court May 15, the bottom line, at least initially, will be whether TKTX can show that claim one

Read the full 303 word article

How to gain access

Continue reading with a
two-week free trial.